Qiagen bolsters assay tech with SABiosciences buy
This article was originally published in Clinica
Executive Summary
Dutch diagnostics firm Qiagen has added to its recent acquisition of companion diagnostics expert DxS by purchasing PCR assay company SABiosciences. Qiagen, which is set to pay up to $130m for DxS, has agreed to spend a further $90m on SABiosciences in an all-cash deal.